Prescription medication is a lifeline for millions of people around the U.S. Unfortunately, the cost of such medications has ...
Sen. Bernie Sanders (I-Vt.) and a group of Senate Democrats on Monday announced an investigation into the high costs of asthma inhalers. Sanders, chairman of the Senate Health, Education, Labor and ...
A recent tweak to a Medicaid formula could be behind the shake-up to inhaler products, a series of changes that have both benefited and harmed patients with asthma and chronic obstructive pulmonary ...
Check out some of the medications affected by drugmakers raising prices on life-saving medications this year, as well as some that will lower in price.
The U.S. healthcare industry is ever evolving, and there is one thing everyone agrees on: it’s complex and often challenging for patients, especially those most vulnerable. One of the complexities ...
Are Americans paying nearly $500 for an inhaler that would cost just $7 overseas? U.S. Sen. Tammy Baldwin, D-Wis., says there is a vast difference in the cost of prescriptions in the United States and ...
A U.S Senate committee sent letters to four top pharmaceutical companies announcing an investigation into the high prices the companies are charging for inhalers. The Senate committee, in a letter to ...
President Joe Biden and Senator Bernie Sanders continue their push to cut the cost of asthma inhalers and prescription drugs in the US. On Wednesday, President Joe Biden and Senator Bernie Sanders (I, ...
A group of Senators on the Health, Education, Labor, and Pensions (HELP) committee on Monday announced a probe into the high costs of asthma inhalers manufactured by listed drugmakers GSK (NYSE:GSK), ...
Drugmaker AstraZeneca will cap out-of-pocket costs at $35 for all its inhaler products, the company announced Monday. The cap is effective June 1 and will apply to the company’s entire range of ...
Experts say a key reason why inhaler prices remain so high in the U.S. is that there is very little generic competition. The Senate committee, in a letter to the pharma CEOs, cited an online global ...